Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LIN | Ordinary Shares | Options Exercise | $8.71M | +85.2K | +147.84% | $102.22 | 143K | Mar 4, 2024 | Direct | |
transaction | LIN | Ordinary Shares | Tax liability | -$22.7M | -49.7K | -34.81% | $456.35 | 93.1K | Mar 4, 2024 | Direct | F1 |
transaction | LIN | Ordinary Shares | Options Exercise | $5.25M | +40.9K | +43.89% | $128.38 | 134K | Mar 4, 2024 | Direct | |
transaction | LIN | Ordinary Shares | Tax liability | -$11.4M | -25.1K | -18.74% | $455.87 | 109K | Mar 4, 2024 | Direct | F1, F2 |
transaction | LIN | Ordinary Shares | Sale | -$23.4M | -51.2K | -47.06% | $455.84 | 57.6K | Mar 4, 2024 | Direct | |
holding | LIN | Ordinary Shares | 3.01K | Mar 4, 2024 | 401(k) |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LIN | Stock Option (right to buy) | Options Exercise | $0 | -40.9K | -100% | $0.00* | 0 | Mar 4, 2024 | Ordinary Shares | 40.9K | $128.38 | Direct | F12 |
transaction | LIN | Stock Option (right to buy) | Options Exercise | $0 | -85.2K | -100% | $0.00* | 0 | Mar 4, 2024 | Ordinary Shares | 85.2K | $102.22 | Direct | F12 |
holding | LIN | Restricted Stock Units | 2.87K | Mar 4, 2024 | Ordinary Shares | 2.87K | Direct | F3 | ||||||
holding | LIN | Restricted Stock Units | 2.6K | Mar 4, 2024 | Ordinary Shares | 2.6K | $0.00 | Direct | F4 | |||||
holding | LIN | Restricted Stock Units | 3.26K | Mar 4, 2024 | Ordinary Shares | 3.26K | $0.00 | Direct | F5 | |||||
holding | LIN | Restricted Stock Units | 3.59K | Mar 4, 2024 | Ordinary Shares | 3.59K | $0.00 | Direct | F6 | |||||
holding | LIN | Stock Option (right to buy) | 19K | Mar 4, 2024 | Ordinary Shares | 19K | $354.14 | Direct | F7 | |||||
holding | LIN | Stock Options (right to buy) | 22.5K | Mar 4, 2024 | Ordinary Shares | 22.5K | $270.99 | Direct | F8 | |||||
holding | LIN | Stock Option (right to buy) | 34.3K | Mar 4, 2024 | Ordinary Shares | 34.3K | $253.68 | Direct | F9 | |||||
holding | LIN | Stock Option (right to buy) | 43.7K | Mar 4, 2024 | Ordinary Shares | 43.7K | $173.13 | Direct | F10 | |||||
holding | LIN | Stock Option (right to buy) | 47K | Mar 4, 2024 | Ordinary Shares | 47K | $176.63 | Direct | F11 | |||||
holding | LIN | Stock Option (right to buy) | 72.8K | Mar 4, 2024 | Ordinary Shares | 72.8K | $118.71 | Direct | F12 | |||||
holding | LIN | Stock Option (right to buy) | 64.7K | Mar 4, 2024 | Ordinary Shares | 64.7K | $154.00 | Direct | F12 | |||||
holding | LIN | Deferred Stock Units | 1.38K | Mar 4, 2024 | Ordinary Shares | 1.27K | Direct | F13, F14 |
Id | Content |
---|---|
F1 | Ordinary shares withheld to cover exercise price and taxes. |
F2 | The price reported is the weighted average sale price. The sale prices ranged from $455.74 to $456.03. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |
F3 | Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis. |
F4 | Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. |
F5 | Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. |
F6 | Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis. |
F7 | This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024. |
F8 | This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023. |
F9 | This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. |
F10 | This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. |
F11 | This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
F12 | This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. |
F13 | Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. |
F14 | Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan. |